The American journal of emergency medicine
-
Multicenter Study
Intranasal ketamine for procedural sedation in children: An open-label multicenter clinical trial.
There are limited options for pain and distress management in children undergoing minor procedures, without the burden of an intravenous line insertion. Prior to this study, we conducted a dose-escalation study and identified 6 mg/kg as a potentially optimal initial dose of intranasal ketamine. ⋯ ClinicalTrials.gov (NCT03053947).